Clinical perception and novel insights of chronic myelomonocytic leukemia: a 10-year multi-center retrospective study
CMML is a highly heterogeneous disease with generally unfavorable clinical outcomes. Although chemotherapy can induce remission in some cases, long-term survival remains limited. The enrollment in clinical trials should be encouraged to improve patient prognosis.
Authors
- Yanquan Liu (ORCID: https://orcid.org/0000-0001-6826-0456)
- Yue Yin (ORCID: https://orcid.org/0000-0001-6210-0427)
- jianzhen shen (ORCID: https://orcid.org/0000-0001-7768-6387)
- Honghua He (ORCID: https://orcid.org/0000-0001-9518-5818)
- Jingdong Zhang (ORCID: https://orcid.org/0000-0003-3236-2754)
- Huidong Guo (ORCID: https://orcid.org/0009-0007-6914-4706)
- Fanlin Zeng
- Zhimin Yan
- Xiaojun Chen
Institutions
- Fujian Medical University (CN)
- Ganzhou People's Hospital (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- First Affiliated Hospital of Gannan Medical University (CN)
- Union Hospital (US)
- Union Hospital (CN)
- Putian University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-01-15
- DOI
- https://doi.org/10.3389/fmed.2025.1711684
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Health Commission of Jiangxi Province